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Solitary fibrous tumors (SFTs) are rare mesenchymal tumors mainly originating in the pleura. Since 
complete resection is the most important prognostic factor, typical surgical approach has been open 
laparotomy. In this report, we present a unusual case of large retropancreatic SFT that was 
successfully treated via laparoscopic resection. A 22-year-old female was diagnosed with a 8×7 
cm-sized well-demarcated mass with multiple loculating and enhancing solid portions on the left 
adrenal fossa. The mass showed no definite invasion of adjacent organs and laparoscopic resection 
was planned. Using blunt dissection and individual vessel ligation, the operation was successful. The 
operative time was 220 minutes, and the amount of intraoperative blood loss was estimated to be 
within 100 ml. The patient recovered without complications. Laparoscopic excision of large 
retroperitoneal SFTs can be safe and feasible if there is no evidence of local invasion or malignancy 
on preoperative radiologic images.
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CASE REPORT
IntroductIon
Solitary fibrous tumor (SFT) is a rare mesenchymal neo-
plasm initially documented as arising from the pleura.1 SFTs 
commonly involve the pleura and abdominopelvic cavity, 
but they can occur in almost every anatomic site and organ.2 
Nearly 30% of SFT has been reported to arise from extrapleu-
ral locations and SFTs arising in the retroperitoneum are rare 
with only a few cases reported.3 The majority of SFTs are re-
garded as benign and only 12~22% are histologically or clini-
cally malignant.4 Typical SFTs show sporadic or no mitotic 
figures with mild nuclear atypia. Malignant SFT is defined 
on the basis of infiltrative margins, hypercellularity, nuclear 
atypia, mitotic index greater than 4/10 high-power fields, and 
necrosis.5 Most SFTs are asymptomatic and present as a pain-
less mass. However, rare and unspecific symptoms may pres-
ent depending on location, most commonly as a local pressure 
effect. Surgical excision is the mainstay of treatment, and 
complete resectability is the most important prognostic factor.5 
For that reason, the surgical approach has typically been open 
laparotomy for reported cases of retroperitoneal SFT.3 
Early in the development of laparoscopic surgery, applica-
tion to retroperitoneal tumors was limited due to technical 
difficulties resulting from the deep location and close prox-
imity to major vessels. With recent advances in laparoscopic 
surgical techniques in the hands of experienced surgeons, 
successful laparoscopic approaches to various retroperitoneal 
tumors, including cystic lymphangioma, schwannoma, gan-
glioneuroma, and liposarcoma, have been reported. In this re-
port, we present a case of a young female patient with a large 
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retropancreatic SFT that was successfully treated via laparo-
scopic resection. 
CASE REpORt
Patient
A 22-year-old female patient was referred to our institution 
for an asymptomatic incidental large retropancreatic mass that 
was found during a routine medical check-up. The patient’s 
past medical history and family history were unremarkable. 
On physical examination, her abdomen was soft and non-
tender without a palpable mass. Initial abdominal ultrasound 
has revealed a 8×7 cm sized well-demarcated and multise-
prated mass on pancreas tail. The mass was in close proximity 
to liver, spleen, and left kidney but borders were well-defined 
without invasion. Initial impression was a cystic neoplasm of 
pancreas tail and further evaluation with abdominal computed 
tomography (CT) and magnetic resonance imaging (MRI) 
scans were performed. The results demonstrated a 8×7 cm 
sized well-demarcated mass with multiple loculating and en-
hancing solid portions on the left adrenal fossa under the left 
side of the pancreas (Fig. 1). Impression after further imaging 
study was a retroperitoneal tumor in left adrenal fossa with a 
differential diagnosis needed for solitary fibrous tumor, gas-
trointestinal stromal tumor, schwannoma, pleomorphic lipoma 
and mucinous cystadenoma. The mass showed a relatively 
smooth margin without definite invasion of adjacent organs. 
Therefore, laparoscopic resection was planned.
Surgery
Under general endotracheal anesthesia, the patient was 
placed on the surgical table in the supine position. The pa-
tient’s head and left side were elevated. A 1.5-cm skin inci-
sion was made over the umbilicus and the peritoneum was 
opened using the open method approach. A 12-mm trocar 
was inserted and CO2 gas was insufflated through the trocar 
at a speed of 20 L/min and up to the intraperitoneal pressure 
of 12 mmHg. After inserting the telescope, positions for two 
working ports on each side of subcostal area were determined. 
Right subcostal port was placed on about 2 cm right side of 
the falciform ligament and left subcostal port was appropri-
ately placed to facilitate easy access to left adrenal fossa. Upon 
laparoscopic examination under the pneumoperitoneum, an 
8 cm solid mass was noted between the kidney, stomach, pan-
creas, and spleen. After division of the gastrocolic ligament, 
the tumor was carefully dissected from the surrounding tissue 
and there was no macroscopic evidence of malignancy; thus, 
the decision was made to continue the laparoscopic approach. 
Since the tumor did not show invasion to the surrounding tis-
sues or organs, careful and blunt dissection around the tumor 
Fig. 1. Preoperative imaging studies. 
Contrast-enhanced abdominal computed 
tomography and magnetic resonance 
imaging revealed a 8.4×7.5-cm mass 
on the left adrenal fossa with internal 
multiple loculations and an enhancing 
solid portion. The mass had a relatively 
smooth margin without definite invasion 
of adjacent organs.
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enabled isolation of feeding vessels. The several feeding ves-
sels that form the celiac axis and splenic hilum were all safely 
controlled and divided (Fig. 2). The tumor was safely delivered 
by a small vertical extension of the umbilical port site. One 
silastic drain was placed into the surgical field. The opera-
tive time was 220 minutes, and the amount of intraoperative 
blood loss was estimated to be within 100 ml during the whole 
laparoscopic procedure. The patient recovered without com-
plications. Oral diet was started immediately and patient was 
discharged on the fifth day after the surgery. The patient was 
followed up for more than 5 years after the surgery without 
evidence of local or systemic recurrence.
Pathological findings
Grossly, the resected mass weighed 150 g and measured 8×
6×6.5 cm. Inside the mass, there were multilocular cysts (3.3×
3 cm in the largest one) with a solid area (4.5×4 cm). The solid 
area was homogeneously grayish pink and soft. On further 
sections, the cyst contained clear fluid and the inner wall of 
the cyst was smooth. The pathologic examination proved that 
the tumor was a solitary fibrous tumor with diffuse positivity 
A B
C D
Fig. 2. Intraoperative laparoscopic views. 
(A) The tumor was identified between the 
kidney, stomach, pancreas and spleen. 
(B, C) Several feeding vessels were noted 
and safely ligated. (D) The successfully 
resected retroperitoneal mass. T = tumor; 
S = spleen; P = pancreas; G = greater 
curvature of the stomach.
A B C
Fig. 3. Pathologic examination: (A) Gross specimen with multilocular cysts and a solid portion. (B) Histological examination of SFT. The tumor consisted 
mainly of spindle-shaped cells (H&E stain, ×100). (C) Immunohistochemical findings of SFT. The tumor cells showed immunoreactivity to CD34 diffusely 
in their cytoplasm.
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for CD 34 and focal positivity for S-100 protein on immuno-
histochemical stain (Fig. 3).
dISCuSSION
Since its first documentation in 1931,1 SFT has long been 
regarded as a rare pleural neoplasm. It is currently believed 
to originate from mesenchymal fibroblast-like cells6 and has 
been shown to involve nearly all body sites.2 SFT has a peak 
incidence in middle-aged adults (range, 20~70 years) and 
affects both sexes equally.7 SFT usually presents as a slow-
growing painless mass or may compress adjacent structures 
causing symptoms like abdominal pain. Although abdomino-
pelvic CT and MRI of a large, solid, well-defined, hypervas-
cular mass with necrosis or cystic degeneration could raise a 
preoperative suspicion of SFT, confirmation of the diagnosis 
still depends on histological and immunohistochemical ex-
amination.
Histologically, the characteristic features of SFT are a pat-
ternless distribution of bland ovoid or spindled fibroblastic 
cells with intercellular dense collagen and interspersed large 
branching thin-walled hemangiopericytic vessels.6 Malignant 
SFT is defined on the basis of infiltrative margins, hypercellu-
larity, nuclear atypia, mitotic index greater than 4/10 high-
power fields, and necrosis.5 Immunohistochemically, several 
proteins such as CD34, vimentin, B cell lymphoma 2 (BCL-2), 
and CD99, are generally considered to have diagnostic value 
for SFT.8 Recently, STAT6 has been reported as a promising 
marker, expression of which is predominantly nuclear in SFT.9 
CD34, a positive marker for SFT, is expressed on the surface 
of lymphohematopoietic stem and progenitor cells, small-ves-
sel endothelial cells, and embryonic fibroblasts.3 SFT typically 
shows diffuse and strong expression of CD34, as well as CD99. 
Positive finding for vimentin, a general marker of cells origi-
nating in the mesenchyme, also support the diagnosis of SFT. 
And Bcl-2, which suppresses apoptosis, has been reported to 
show positive reactivity in 75% of extrapleural SFT.3 In our 
case, diffusely positive CD34 was found on pathology, thus 
establishing a diagnosis of SFT. CD31, S-100 protein, desmin, 
and cytokeratins are usually absent in SFT. Nevertheless, some 
focal expression of those markers has been reported,10 includ-
ing our case of focal positivity for S-100.
The differential diagnosis of SFT includes schwannoma, 
spindle cell/pleomorphic lipoma, dermatofibrousarcoma pro-
tuberans, gastrointestinal stromal tumors, dedifferentiated 
liposarcoma, well-differentiated liposarcoma, and synovial 
sarcoma; immunohistochemical staining and cytogenetic fea-
tures can be used for differentiation. 
SFT has been reported to show unpredictable behavior; 
even SFTs without malignant histologic features can abruptly 
dedifferentiate into aggressive soft tissue sarcoma. Therefore, 
long-term follow-up is required. According to van Houdt et 
al.,8 5-year local recurrence and metastasis rate after the op-
eration with curative intent were 29 and 34%, respectively. The 
5-year overall survival was reported to be 84%. While SFT is 
generally regarded as benign, substantial amount of patients 
develop recurrence or metastasis. Therefore, long-term follow 
up period is necessary. Among the factors related to recur-
rence and metastasis, positive resection margin has been as-
sociated with a higher local recurrence rate, whereas large 
tumor size (>10 cm) and high mitosis rate (>4 per 10 HPFs) 
correlated with higher metastasis rate.
Wide surgical excision is the standard treatment of SFTs, 
and margin negative resection is the most important prog-
nostic factor, in view of its unpredictable nature.8 Retroperi-
toneal SFTs are rare and traditionally have been treated via 
open laparotomy rather than laparoscopic surgery to ensure 
margin-negative, and safe resection. With recent advances in 
laparoscopic technique, along with improved imaging mo-
dalities, laparoscopic resection of retroperitoneal tumors has 
become feasible, even in cases of large tumors in difficult 
locations such as close to the vena cava or aorta. Herein, we 
presented a case of large retroperitoneal SFT treated with 
laparoscopic resection. In spite of its large size and the need 
for ligation of feeding vessels from the celiac axis and splenic 
hilum, laparoscopic excision was feasible and safe, with mini-
mal invasiveness, early postoperative recovery and cosmetic 
benefits. Successful laparoscopic excision was made possible, 
because SFT had no local invasion to surrounding tissue with 
margins well-demarcated. Careful blunt dissection around the 
tumor allowed isolation of feeding vessels and individual liga-
tion of vessels. The quality of life of the young female patient 
was not compromised and there has been no evidence of local 
or systemic recurrence in the 5 years after surgery. 
 In conclusion, laparoscopic excision of large retroperitoneal 
SFTs can be safe and feasible if there is no evidence of lo-
cal invasion or malignancy on preoperative radiologic images. 
However, adequate long-term follow-up is necessary due to 
the possibility of late recurrence.
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